Latest News and Press Releases
Want to stay updated on the latest news?
-
ST. LOUIS, Jan. 23, 2008 (PRIME NEWSWIRE) -- Solutia Inc. (NYSE:SOA) announced today that the effective date of its confirmed plan of reorganization and its emergence from Chapter 11 will be delayed...
-
Indre værdi er dags dato opgjort til kr. 612,2 pr. aktie. Med venlig hilsen Formuepleje Epikur A/S Bruuns Galleri Værkmestergade 25 DK-8000 Århus C Telefon +45 8746 4900 Telefax +45 8746...
-
På grund af faldende kurser i Europa over middag offentliggøres ny indre værdi. Indre værdi er opgjort til kr. 136,2 pr. aktie. Med venlig hilsen Formuepleje Safe A/S Bruuns...
-
MOUNTAIN VIEW, CA--(Marketwire - January 23, 2008) - Kazeon Systems, Inc., a leading provider of intelligent eDiscovery solutions, today announced that Gartner has rated Kazeon "Positive" in Gartner,...
-
TAMPA, FL--(Marketwire - January 23, 2008) - FTS Group, Inc. (OTCBB: FLIP), a publicly traded acquisition and development Company operating in the Wireless, Internet and Technology industries today...
-
Company Expects $30m in Annual Revenues and 5-7 Percent Operating Margin in 2008 Preliminary Fourth Quarter 2007 Results Show Revenues of $7 - 7.5 Million ...
-
NEW YORK, Jan. 23, 2008 (PRIME NEWSWIRE) -- Viewpointe, the leading provider of check image and Check 21-related services, announced today that Bremer Bank, St. Paul, Minn., has become the latest...
-
SAN JOSE, Calif., Jan. 23, 2008 (PRIME NEWSWIRE) -- Magma(r) Design Automation, Inc. (Nasdaq:LAVA), a provider of chip design software, today introduced 3D Small-Area Analysis, an option to Magma's...
-
LAKE SUCCESS, N.Y., Jan. 23, 2008 (PRIME NEWSWIRE) -- Flushing Financial Corporation (the "Company") (Nasdaq:FFIC), the parent holding company for Flushing Savings Bank, FSB, today announced it will...
-
Elite Pharmaceuticals, Inc. Retains The Global Consulting Group as Strategic Communications Advisors
NORTHVALE, N.J, Jan. 23, 2008 (PRIME NEWSWIRE) -- Elite Pharmaceuticals, Inc. (AMEX:ELI), a leading drug delivery, specialty pharmaceutical company focused primarily on producing proprietary abuse...